“Guest Editor: Pellegrino Musto HOW FIRST LINE THERAPY IS CHANGING IN TRANSPLANT-ELIGIBLE MULTIPLE MYELOMA PATIENTS”. 2025. Mediterranean Journal of Hematology and Infectious Diseases 17 (1): e2025026. https://doi.org/10.4084/MJHID.2025.026.